Literature DB >> 23719203

Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension.

Jana Radosinska1, Barbara Bacova, Vladimir Knezl, Tamara Benova, Jitka Zurmanova, Tomas Soukup, Petra Arnostova, Jan Slezak, Eva Gonçalvesova, Narcisa Tribulova.   

Abstract

OBJECTIVE: Hypertension-induced myocardial remodeling is known to be associated with increased risk for malignant arrhythmias and alterations in electrical coupling protein, connexin-43 (Cx43), may be involved. We investigated whether omega-3 fatty acids intake affects abnormalities of Cx43 as well as protein kinase C (PKC) signaling and myosin heavy chain (MyHC) profile at the early and late stage of hypertension in the context of the heart's susceptibility to ventricular fibrillation and ability to restore sinus rhythm.
METHODS: Untreated young and old male spontaneously hypertensive rats (SHRs) and age-matched normotensive rats were compared with animals supplemented by omega-3 (eicosapentaneoic acid + docosahexaneoic acid, 200 mg/kg body weight/day) for 2 months. Left ventricular tissues were taken for examination of subcellular integrity of gap junctions, Cx43 mRNA and protein expression, PKCε and PKCδ as well as MyHC determination. Electrically inducible ventricular fibrillation and sinus rhythm restoration (SRR) were examined on Langedorff-perfused heart preparation.
RESULTS: Omega-3 intake significantly reduced cardiovascular risk factors, suppressed inducible ventricular fibrillation, and facilitated SRR in hypertensive rats. Supplementation attenuated lateralization and internalization of Cx43, suppressed elevated Cx43 mRNA, enhanced total Cx43 protein expression and/or expression of its functional phosphorylated forms as well as the expression of cardioprotective PKC-ε and suppressed pro-apoptotic PKC-δ isoform. Moreover, the omega-3 diet normalized MyHC profiles in SHR at early stage of disease and old nonhypertensive rats, but failed to do so in old SHR at late stage of disease.
CONCLUSION: Findings suggest that amelioration of myocardial Cx43-related abnormalities, positive modulation of PKC pathways, and normalization of MyHC can significantly contribute to the antiarrhythmic effects of omega-3 in rat model mimicking human essential hypertension. Our results support the prophylactic use of omega-3 to minimize cardiovascular risk and sudden arrhythmic death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719203     DOI: 10.1097/HJH.0b013e328362215d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

1.  Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.

Authors:  Jingying Hou; Lingyun Wang; Jinghui Hou; Tianzhu Guo; Yue Xing; Shaoxin Zheng; Changqing Zhou; Hui Huang; Huibao Long; Tingting Zhong; Quanhua Wu; Jingfeng Wang; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

2.  Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats.

Authors:  Tamara Egan Benova; Csilla Viczenczova; Barbara Szeiffova Bacova; Vladimir Knezl; Victor Dosenko; Hana Rauchova; Michal Zeman; Russel J Reiter; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2018-11-16       Impact factor: 3.396

Review 3.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 5.  Epicardial adipose tissue as a mediator of cardiac arrhythmias.

Authors:  Kiran Haresh Kumar Patel; Taesoon Hwang; Curtis Se Liebers; Fu Siong Ng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 4.733

6.  Altered thyroid status affects myocardial expression of connexin-43 and susceptibility of rat heart to malignant arrhythmias that can be partially normalized by red palm oil intake.

Authors:  Barbara Szeiffová Bačová; Csilla Vinczenzová; Jitka Žurmanová; Dita Kašparová; Vladimír Knezl; Tamara Egan Beňová; Stanislav Pavelka; Tomáš Soukup; Narcisa Tribulová
Journal:  Histochem Cell Biol       Date:  2016-09-06       Impact factor: 4.304

7.  Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy.

Authors:  Zhukovska Anna; Shysh Angela; Bacova Barbara; Radosinska Jana; Benova Tamara; Viczenczova Csilla; Dosenko Victor; Moybenko Oleksiy; Tribulova Narcisa
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

Review 8.  Regulation of Connexin-Based Channels by Fatty Acids.

Authors:  Carlos Puebla; Mauricio A Retamal; Rodrigo Acuña; Juan C Sáez
Journal:  Front Physiol       Date:  2017-01-24       Impact factor: 4.566

9.  The effect of omega- 3 polyunsaturated fatty acids on endothelial tight junction occludin expression in rat aorta during lipopolysaccharide-induced inflammation.

Authors:  Jakub Krizak; Karel Frimmel; Iveta Bernatova; Jana Navarova; Ruzena Sotnikova; Ludmila Okruhlicova
Journal:  Iran J Basic Med Sci       Date:  2016-03       Impact factor: 2.699

10.  Chronic Omega-3 Polyunsaturated Fatty Acid Treatment Variably Affects Cellular Repolarization in a Healed Post-MI Arrhythmia Model.

Authors:  Ingrid M Bonilla; Yoshinori Nishijima; Pedro Vargas-Pinto; Stephen H Baine; Arun Sridhar; Chun Li; George E Billman; Cynthia A Carnes
Journal:  Front Physiol       Date:  2016-06-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.